Literature DB >> 2809202

Structural requirements for the interaction between peptide antigens and I-Ed molecules.

A Sette1, L Adorini, E Appella, S M Colón, C Miles, S Tanaka, C Ehrhardt, G Doria, Z A Nagy, S Buus.   

Abstract

We have analyzed the structural characteristics of the interaction between I-Ed molecules and their peptide ligands. It was found that unrelated good I-Ed binders share structurally similar "core" regions that were experimentally demonstrated to be crucial for binding to I-Ed molecules. Single amino acid substitution analogues of one good I-Ed binder, hen egg lysozyme 107-116, were analyzed for their capacity to bind to I-Ed molecules and to activate two different I-Ed-restricted T cell hybridomas. The results illustrate the great permissiveness of I-Ed-peptide interaction and the great specificity of T cell recognition. It was concluded from these analyses that basic residues on the peptide molecule play a crucial role in binding to I-Ed. This contrasts with the structural requirements for binding to the other Iad isotype, I-Ad, the crucial hydrophobic residues. Thus, different class II molecules of the same MHC haplotype may have rather distinct peptide binding specificities, thereby expanding the repertoire of possible immunogenic peptides presented for T cell recognition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809202

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.

Authors:  W Gerhard; A M Haberman; P A Scherle; A H Taylor; G Palladino; A J Caton
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase).

Authors:  Kirk D C Jensen; Eli E Sercarz; Claudia Raja Gabaglia
Journal:  Mol Immunol       Date:  2008-11-29       Impact factor: 4.407

3.  Self peptide requirement for class II major histocompatibility complex allorecognition.

Authors:  S Demotz; A Sette; K Sakaguchi; R Buchner; E Appella; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

4.  Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens.

Authors:  A Jepson; W Banya; F Sisay-Joof; M Hassan-King; C Nunes; S Bennett; H Whittle
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Enhancement of peptide antigen presentation by a second peptide.

Authors:  A I de Kroon; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

6.  Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus.

Authors:  A M Boots; J G Kusters; J M van Noort; K A Zwaagstra; E Rijke; B A van der Zeijst; E J Hensen
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

7.  Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.

Authors:  A C Griffin; W Zhao; K W Wegmann; W F Hickley
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

8.  Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants.

Authors:  R Cibotti; J M Kanellopoulos; J P Cabaniols; O Halle-Panenko; K Kosmatopoulos; E Sercarz; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

9.  Delineation of antigen contact residues on an MHC class II molecule.

Authors:  J Peccoud; P Dellabona; P Allen; C Benoist; D Mathis
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  H-2Kd-restricted antigenic peptides share a simple binding motif.

Authors:  P Romero; G Corradin; I F Luescher; J L Maryanski
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.